The global immunoassay market size accounted for USD 35.57 billion in 2024, grew to USD 37.23 billion in 2025 and is predicted to surpass around USD 56.2 billion by 2034, representing a healthy CAGR of 4.68% between 2024 and 2034. The North America immunoassay market size is calculated at USD 12.81 billion in 2024 and is expected to grow at a fastest CAGR of 4.81% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Immunoassay Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Immunoassay Market, by Product
8.1.1. Reagents & Kits
8.1.1.1. Market Revenue and Forecast
8.1.2. Analyzer
8.1.2.1. Market Revenue and Forecast
8.1.3. Software and Services
8.1.3.1. Market Revenue and Forecast
9.1. Immunoassay Market, by Technology
9.1.1. ELISA
9.1.1.1. Market Revenue and Forecast
9.1.2. Rapid Tests
9.1.2.1. Market Revenue and Forecast
9.1.3. ELISpot
9.1.3.1. Market Revenue and Forecast
9.1.4. Western Blotting
9.1.4.1. Market Revenue and Forecast
9.1.5. Radioimmunoassay
9.1.5.1. Market Revenue and Forecast
9.1.6. Other technologies
9.1.5.1. Market Revenue and Forecast
10.1. Immunoassay Market, by Specimen
10.1.1. Blood
10.1.1.1. Market Revenue and Forecast
10.1.2. Saliva
10.1.2.1. Market Revenue and Forecast
10.1.3. Urine
10.1.3.1. Market Revenue and Forecast
10.1.4. Other Specimen
10.1.4.1. Market Revenue and Forecast
11.1. Immunoassay Market, by Application
11.1.1. Infectious diseases
11.1.1.1. Market Revenue and Forecast
11.1.2. Endocrinology
11.1.2.1. Market Revenue and Forecast
11.1.3. Oncology
11.1.3.1. Market Revenue and Forecast
11.1.4. Bone and mineral disorders
11.1.4.1. Market Revenue and Forecast
11.1.5. Cardiology
11.1.5.1. Market Revenue and Forecast
11.1.6. Blood screening
11.1.6.1. Market Revenue and Forecast
11.1.7. Autoimmune Disorders
11.1.7.1. Market Revenue and Forecast
11.1.8. Allergy Diagnostics
11.1.8.1. Market Revenue and Forecast
11.1.9. Toxicology
11.1.9.1. Market Revenue and Forecast
11.1.10. Newborn Screening
11.1.10.1. Market Revenue and Forecast
11.1.11. Other Application
11.1.11.1. Market Revenue and Forecast
12.1. Immunoassay Market, by End-User
12.1.1. Hospitals & Clinics
12.1.1.1. Market Revenue and Forecast
12.1.2. Clinical Laboratories
12.1.2.1. Market Revenue and Forecast
12.1.3. Pharmaceutical & Biotechnology Companies And Cro
12.1.3.1. Market Revenue and Forecast
12.1.4. Blood Banks
12.1.4.1. Market Revenue and Forecast
12.1.5. Research & Academic Laboratories
12.1.5.1. Market Revenue and Forecast
12.1.6. Home Care Setting
12.1.6.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product
13.1.2. Market Revenue and Forecast, by Technology
13.1.3. Market Revenue and Forecast, by Specimen
13.1.4. Market Revenue and Forecast, by Application
13.1.5. Market Revenue and Forecast, by End-User
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product
13.1.6.2. Market Revenue and Forecast, by Technology
13.1.6.3. Market Revenue and Forecast, by Specimen
13.1.6.4. Market Revenue and Forecast, by Application
13.1.6.5. Market Revenue and Forecast, by End-User
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product
13.1.7.2. Market Revenue and Forecast, by Technology
13.1.7.3. Market Revenue and Forecast, by Specimen
13.1.7.4. Market Revenue and Forecast, by Application
13.1.7.5. Market Revenue and Forecast, by End-User
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product
13.2.2. Market Revenue and Forecast, by Technology
13.2.3. Market Revenue and Forecast, by Specimen
13.2.4. Market Revenue and Forecast, by Application
13.2.5. Market Revenue and Forecast, by End-User
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product
13.2.6.2. Market Revenue and Forecast, by Technology
13.2.6.3. Market Revenue and Forecast, by Specimen
13.2.7. Market Revenue and Forecast, by Application
13.2.8. Market Revenue and Forecast, by End-User
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product
13.2.9.2. Market Revenue and Forecast, by Technology
13.2.9.3. Market Revenue and Forecast, by Specimen
13.2.10. Market Revenue and Forecast, by Application
13.2.11. Market Revenue and Forecast, by End-User
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product
13.2.12.2. Market Revenue and Forecast, by Technology
13.2.12.3. Market Revenue and Forecast, by Specimen
13.2.12.4. Market Revenue and Forecast, by Application
13.2.13. Market Revenue and Forecast, by End-User
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product
13.2.14.2. Market Revenue and Forecast, by Technology
13.2.14.3. Market Revenue and Forecast, by Specimen
13.2.14.4. Market Revenue and Forecast, by Application
13.2.15. Market Revenue and Forecast, by End-User
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product
13.3.2. Market Revenue and Forecast, by Technology
13.3.3. Market Revenue and Forecast, by Specimen
13.3.4. Market Revenue and Forecast, by Application
13.3.5. Market Revenue and Forecast, by End-User
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product
13.3.6.2. Market Revenue and Forecast, by Technology
13.3.6.3. Market Revenue and Forecast, by Specimen
13.3.6.4. Market Revenue and Forecast, by Application
13.3.7. Market Revenue and Forecast, by End-User
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product
13.3.8.2. Market Revenue and Forecast, by Technology
13.3.8.3. Market Revenue and Forecast, by Specimen
13.3.8.4. Market Revenue and Forecast, by Application
13.3.9. Market Revenue and Forecast, by End-User
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product
13.3.10.2. Market Revenue and Forecast, by Technology
13.3.10.3. Market Revenue and Forecast, by Specimen
13.3.10.4. Market Revenue and Forecast, by Application
13.3.10.5. Market Revenue and Forecast, by End-User
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product
13.3.11.2. Market Revenue and Forecast, by Technology
13.3.11.3. Market Revenue and Forecast, by Specimen
13.3.11.4. Market Revenue and Forecast, by Application
13.3.11.5. Market Revenue and Forecast, by End-User
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product
13.4.2. Market Revenue and Forecast, by Technology
13.4.3. Market Revenue and Forecast, by Specimen
13.4.4. Market Revenue and Forecast, by Application
13.4.5. Market Revenue and Forecast, by End-User
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product
13.4.6.2. Market Revenue and Forecast, by Technology
13.4.6.3. Market Revenue and Forecast, by Specimen
13.4.6.4. Market Revenue and Forecast, by Application
13.4.7. Market Revenue and Forecast, by End-User
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product
13.4.8.2. Market Revenue and Forecast, by Technology
13.4.8.3. Market Revenue and Forecast, by Specimen
13.4.8.4. Market Revenue and Forecast, by Application
13.4.9. Market Revenue and Forecast, by End-User
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product
13.4.10.2. Market Revenue and Forecast, by Technology
13.4.10.3. Market Revenue and Forecast, by Specimen
13.4.10.4. Market Revenue and Forecast, by Application
13.4.10.5. Market Revenue and Forecast, by End-User
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product
13.4.11.2. Market Revenue and Forecast, by Technology
13.4.11.3. Market Revenue and Forecast, by Specimen
13.4.11.4. Market Revenue and Forecast, by Application
13.4.11.5. Market Revenue and Forecast, by End-User
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product
13.5.2. Market Revenue and Forecast, by Technology
13.5.3. Market Revenue and Forecast, by Specimen
13.5.4. Market Revenue and Forecast, by Application
13.5.5. Market Revenue and Forecast, by End-User
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product
13.5.6.2. Market Revenue and Forecast, by Technology
13.5.6.3. Market Revenue and Forecast, by Specimen
13.5.6.4. Market Revenue and Forecast, by Application
13.5.7. Market Revenue and Forecast, by End-User
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product
13.5.8.2. Market Revenue and Forecast, by Technology
13.5.8.3. Market Revenue and Forecast, by Specimen
13.5.8.4. Market Revenue and Forecast, by Application
13.5.8.5. Market Revenue and Forecast, by End-User
14.1. Abbott Laboratories
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Danaher Corporation (Beckman Coulter)
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Quidel Corporation
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Ortho Clinical Diagnostics
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Sysmex Corporation
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Bio-Rad Laboratories, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Becton, Dickinson, and Company
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. F. Hoffmann-La Roche AG
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Thermo Fisher Scientific, Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Siemens Healthinners
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample